tag:blogger.com,1999:blog-5199522738412628687.post8797421473321782790..comments2011-03-17T08:46:05.464-05:00Wendy W. Blackburnhttp://www.blogger.com/profile/01712567520098554819noreply@blogger.comBlogger2125tag:blogger.com,1999:blog-5199522738412628687.post-37416431136383832212011-03-17T08:46:05.464-05:002011-03-17T08:46:05.464-05:00Great insights, Nalts. You're right - the treatment is just part of an overall situation that patients must deal with. I hope too that, with pharma's resources, they can be a bigger partner to patients than they have been in the past . Thanks for keeping the conversation going!Wendy W. Blackburnhttp://www.blogger.com/profile/01712567520098554819noreply@blogger.comtag:blogger.com,1999:blog-5199522738412628687.post-56087927849610264872011-03-17T05:23:20.464-05:002011-03-17T05:23:20.464-05:00Well timed. Had an opportunity to hear a bunch of consumer presentations about the influence of social norms, emotional cues... the take-home? Let's stop whining about the language we can/can't use and focus on connecting with the patient and helping them see us as a partner in reaching their goals. People don't want to focus on the treatment as much as the goals they have that are being impaired by their illness. I've always thought great CPG marketers would help reinvent pharma and I'm finally seeing it happen selectively. Good for the companies, and more importantly to the patients who indeed don't want to dwell on their illness... just want to get back to living without it.Naltshttp://www.blogger.com/profile/12079508185343293669noreply@blogger.com